Robots, big data, and biotech. That’s the innovation landscape of Boston in a nutshell. But how will things evolve over the next 20 years?
We’ve been asking top leaders in the startup and business community to think about that question, and the opportunities and challenges it presents for innovators across sectors. The answers they give are pretty telling.
It’s all part of Xconomy’s upcoming conference called Boston 2035, the latest in our Xponential Cities series. It’s happening on June 17 at Babson College, and the goal is to get a bunch of top minds together in the same room and discuss where things are headed when it comes to New England’s talent pool, technology companies, life sciences businesses, and venture capital community. The results should be entertaining, inspiring, and surprising.
Meanwhile, here’s the next batch of 2035 prediction videos from representatives of some of Boston’s major growth sectors, and pillar companies in life sciences, big data, and robotics.
First up is Stéphane Bancel, CEO of Moderna Therapeutics, which has already made some of the biggest biotech deals in history:
Next is Andy Palmer, CEO of Tamr, which is transforming how companies deal with their data. He is a rare breed who understands both the tech and life sciences industries, and the importance of nurturing the next generation of entrepreneurs:
Lastly we have Chris Jones, iRobot’s Director of Strategic Technology Development. He’s in charge of R&D, so if you want to know what will be standard home-robot fare in 2035, he’s your man. I also kept expecting him to walk out from behind the telepresence robot in the video:
See you all on June 17! Be sure to bring your ideas and questions.
Ashley Gentile contributed to this report.